Internal Neuromodulation Devices: Core Growth Enabler in the Rising Incidence Of Neurologic Diseases Fuels Growth In The Internal Neuromodulation Devices Market Market, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Internal Neuromodulation Devices Industry Market Size Be by 2025?
In recent years, the market size of internal neuromodulation devices has witnessed substantial growth. It is projected to expand from $2.59 billion in 2024 to $2.75 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 6.0%. Factors contributing to this growth during the historical period include the need for chronic pain management, an aging population, clinical research and trials, the prevalence of neurological disorders, and heightened patient awareness and acceptance.

What's the Long-Term Growth Forecast for the Internal Neuromodulation Devices Market Size Through 2029?
In the upcoming years, the market for internal neuromodulation devices is predicted to experience substantial expansion, reaching $3.87 billion in 2029 with an 8.9% compound annual growth rate (CAGR). This expansion during the forecast period can be attributed to the trends in personalized medicine, increased spending on healthcare, persistent collaborations and partnerships, impact on patient outcomes, and changes in the regulatory environment. The major trends expected in this time frame include advancement towards miniaturization and implantable technology, integration of wireless connectivity and remote monitoring systems, broader applications of neuromodulation, advent of closed-loop systems for precise modulation, and a heightened emphasis on patient-centric designs.

View the full report here:
https://www.thebusinessresearchcompany.com/report/internal-neuromodulation-devices-global-market-report

What Are the Key Growth Drivers Fueling the Internal Neuromodulation Devices Market Expansion?
The rise in neurological conditions is set to propel the expansion of the internal neuromodulation devices market. These devices, which are used in treating disorders affecting the nervous systems such as the brain, spinal cord, and peripheral nerves, have become increasingly necessary due to the spectrum of neurologic diseases. These medical devices administer electrical stimulation to targeted areas of the nervous system, thus offering relief for conditions like chronic pain, mobility disorders, and mood imbalances. They enhance the quality of life for patients by alleviating symptoms and facilitating the performance of daily tasks. For example, the National Library Medicine in the United States reported in April 2023 that 6.7 million Americans were living with Alzheimer's disease, and this figure is expected to nearly double to 13.8 million by 2060. Similarly, according to the House of Lords Library in the UK in May 2022, the neurology workforce in England recorded a significant growth from 1,468 in 2020, to 1,562 in 2021 and 1,638 full-time equivalent staff as of January 31, 2022. Consequently, the escalating prevalence of neurological diseases is fueling the growth of the internal neuromodulation devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10222&type=smp

What Long-Term Trends Will Define the Future of the Internal Neuromodulation Devices Market?
Trend 1 speaks on the notable increase in product innovations within the internal neuromodulation devices market. Major market players are continually creating new technologies to maintain their market dominance. For instance, Neuromod Device Ltd., a medical equipment manufacturer based in Ireland, revealed in March 2023 that the US FDA had granted De Novo clearance to their Lenire system. This system utilizes both sound stimulation and tongue stimulation to address tinnitus, a neurological condition marked by ear ringing. The Lenire system relies on a two-fold neurostimulation method. Bluetooth headphones emit distinct sounds designed to stimulate the auditory nerve, while Neuromod's Tonguetip device, which is placed within the mouth, delivers a certain amount of electrical stimulation to the surface of the tongue. Given these advancements, an otolaryngologist can suggest the Lenire technology to patients who are significantly affected by tinnitus.

How Is the Internal Neuromodulation Devices Market Segmented?
The internal neuromodulation devices market covered in this report is segmented -

1) By Type: Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neuro Stimulator
2) By Technology Type: Internal Neuromodulation, External Neuromodulation
3) By Biomaterial: Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials
4) By Application: Failed Back Surgery Syndrome, Parkinson's Disease, Urinary Incontinence, Epilepsy, Gastroparesis
5) By End-User: Hospitals, Clinics, Home Healthcare, Community Healthcare

Subsegments:
1) By Spinal Cord Stimulator: Traditional Spinal Cord Stimulator, Rechargeable Spinal Cord Stimulator, Non-Rechargeable Spinal Cord Stimulator
2) By Deep Brain Stimulator: Single Lead Deep Brain Stimulator, Dual Lead Deep Brain Stimulator, Adaptive Deep Brain Stimulator
3) By Sacral Nerve Stimulator: Implantable Sacral Nerve Stimulator, External Sacral Nerve Stimulator
4) By Vagus Nerve Stimulator: Implantable Vagus Nerve Stimulator, Transcutaneous Vagus Nerve Stimulator
5) By Gastric Neuro Stimulator: Implantable Gastric Neuro Stimulator, External Gastric Neuro Stimulator

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10222&type=smp

Which Companies Are Leading the Charge in Internal Neuromodulation Devices Market Innovation?
Major companies operating in the internal neuromodulation devices market include Medtronic plc, Boston Scientific Corporation, BioControl Medical Ltd., Aleva Neurotherapeutics SA, Bioness Inc., Uroplasty Inc., Abbott Laboratories, EnteroMedics Inc., LivaNova plc, NeuroPace Inc., Synapse Biomedical Inc., Soterix Medical Inc., Neuros Medical Inc., Nevro Corp., Nuvectra Corporation, Stimwave Technologies Incorporated, SPR Therapeutics, Axonics Modulation Technologies Inc., Saluda Medical Pty Limited, MicroTransponder Inc., EndoStim Inc., NeuroMetrix Inc., Second Sight Medical Products Inc., Neurotech International Limited, Neuronix Ltd., Neuronoff Inc.

Which Regions Are Leading the Global Internal Neuromodulation Devices Market in Revenue?
North America was the largest region in the internal neuromodulation devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global internal neuromodulation devices market report during the forecast period. The regions covered in the internal neuromodulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10222

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.